Under Title 42, migrants seeking asylum at the border were turned away as part of a public health policy to mitigate the spread of COVID-19.

Have you ever spent a summer evening outside with friends only to find, hours later, that you’re covered in mosquito bites? Meanwhile, the people you were hanging out with have none. New research suggests that the soap you wash with could be to blame.

Today we have gathered some of the best examples of design that alleviates life with and for children. Whether it’s something that helps parents to handle their little ones, or solutions that aid the kids themselves, these people knew exactly what would come in handy for one of the two groups. Their ingenious designs cover everything from tiny doors to playtime areas at the dentist’s, and much more.

Self-exclusion was one of the topics related to technology covered by the panel

Students from the Kirk Kerkorian School of Medicine at UNLV recently received their Doctor of Medicine degrees when they walked across the stage at the Thomas & Mack Center. We caught up with some of them excited for the next step.

Lighthouse Pharmaceuticals, a clinical-stage pharmaceutical company developing therapeutics to alter the course of dementia and other degenerative diseases, announced completion of a Pre-investigational New Drug meeting with the Food and Drug Administration related to the planned Phase 2b clinical study of LHP588 and the formation of its Clinical Advisory Board (CAB). The CAB includes six members with diverse backgrounds and expertise in dementia, Alzheimer’s disease, inflammation, neurodegenerative disorders, and drug development.

UNLV Vice President of Economic Development Bo Bernhard recalled how two years ago, the university’s new president wanted to see cutting-edge high-tech companies populate the school’s recently opened Harry Reid Research & Technology Park.

A new drug shows promising results in trials, but questions remain about whether benefits outweigh side effects.